Both in Pharmaceuticals
Lipocine vs Tvardi Therapeutics
Over the past year LPCN returned −43.1% and TVRD returned −80.4%; their daily moves had a correlation of 0.02.
LPCN −43.1% TVRD −80.4%Growth of $1, one year, split-adjusted
| Metric | LPCN | TVRD |
|---|---|---|
| Price | $1.44 | $0.8614 |
| Market cap | $11.9M | $11.5M |
| Today | −1.37% | +3.17% |
| 1 month | −31.4% | −20.2% |
| 6 months | −40.7% | −76.5% |
| Year to date | −82.1% | −80.0% |
| 1 year | −45.7% | −80.9% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 9.4× | — |
| Net cash | $23.3M | $15.8M |
| Dividend yield | — | — |
| Volatility (60d) | 57.5% | 88.7% |
| Short % of float | 4.6% | 6.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).